Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

Inaki Lete, Ainara Martinez,Irene Lasaga, Eva Centurion, Amaia Vesga

GYNECOLOGICAL ENDOCRINOLOGY(2024)

引用 0|浏览3
暂无评分
摘要
In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.
更多
查看译文
关键词
Polycystic ovary syndrome,inositol,MYO/DCI ratio
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要